#132 Clinical Case Review I
Program Summary:
Complex chronic illness cases are difficult at best. The “layering” effect of immune deregulation, toxicants, infections, endocrine disorders and the like have endless potential combinations and presentations. The approach to such cases is also seemingly an endless list of options. In this three-part series we will discuss the origins of these presentations, likely approaches to them, and methods to prioritize and strategize treatment.
Learning Objectives:
- Describe the portions of a complex case
- Define the primary immune disruptors
- Describe a method of assessment
- Discuss the management of multiple infections
CME Effective Date:
Live Event: October 21st, 2025
CME Expiration Date:
Enduring: October 20th, 2027
Educational Credits:
1.5 AMA/PRA Category 1 CME Credit™
1.5 Nursing Contact Hours (0.5 Pharmacologic Hours)
Target Audience:
This program is intended for: Physicians (MD, ND, Other), Nurses, Nurse Practitioners, and Other Healthcare professionals
Conflict of Interest Disclosure Policy
Identify, Mitigate, and Disclose Relevant Financial Relationships
Many healthcare professionals have financial relationships with ineligible companies. These relationships must not be allowed to influence accredited continuing education. The Foundation for Care Management (FCM) as the accredited provider is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these to ensure they do not introduce commercial bias into the education. Financial relationships are defined as relevant if the educational content is related to the business lines or products of the ineligible company. As an accredited provider FCM collects information from planners, faculty and others in control of educational content and conducts an extensive review process. Financial relationships are identified, reviewed and mitigated. In some cases. speakers and committee members may be excluded. All relevant financial relationships are disclosed to the learner below as required by the ACCME.
Disclosures:
Planner/Presenter: Dr. Paul Anderson discloses the following: NFH – Vitazan; Science Advisory Board Member, MD Lifespan; Science Advisory Board Member, Priority One; Formulation Advisor.
Reviewers: Kenneth Meyer discloses no financial relationships with any ineligible companies.
No individual(s) at the Foundation for Care Management (FCM) who had control over the planning or content of this activity has relevant financial relationships with ineligible companies.
To the degree possible all identifying “commercial” detail has been left out of the slides.
Any proprietary products mentioned in the audio Q&A are only due to direct clarifying questions by the attendees, and no product, lab or supplier has any financial connection to the presenter.
Accreditation Statement:
Washington State ND’s: This CME is co-accredited by WANP which allows WA State Category-1 CME Credit for WA Licensed ND’s
In support of improving patient care, this activity has been planned and implemented by the Foundation for Care Management (FCM) and P S Anderson LLC. FCM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This program is approved for 1.5 AMA Category 1 CreditsTM
This program is approved for 1.5 Nursing Contact Hours (0.5 Pharmacologic hours).
Healthcare providers should only claim credit commensurate with the extent of their participation in this activity.
